(Q32064653)

6 July 2017

1 reference

title

Neurobiology of generalized anxiety disorder (English)

1 reference

generalized anxiety disorder

6 July 2017

1 reference

1 reference

Jetty PV

1

1 reference

PubMed ID

11225510

6 July 2017

Charney DS

series ordinal

2

1 reference

PubMed ID

11225510

6 July 2017

Goddard AW

series ordinal

3

1 reference

6 July 2017

1 March 2001

1 reference

Psychiatric Clinics of North America

6 July 2017

1 reference

6 July 2017

24

1 reference

6 July 2017

75-97

1 reference

6 July 2017

1

1 reference

Blunted growth hormone response to clonidine in patients with generalized anxiety disorder

6 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Toward a definition of generalized anxiety disorder as an anxious temperament type.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

The genetics of six neurotic disorders: a twin study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Neurosteroids: a novel function of the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

GR159897, a potent non-peptide antagonist at tachykinin NK2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Elevated plasma levels of neuropeptide Y in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

The cholecystokinin hypothesis of panic and anxiety disorders: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Anxiolytic activity of NPY receptor agonists in the conflict test

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Response to lactate infusion in generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Candidate gene study of eight GABAA receptor subunits in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Slow wave sleep and 5-HT2 receptor sensitivity in generalised anxiety disorder: a pilot study with ritanserin

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Neurobiology of fear responses: the role of the amygdala

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Clinical perspectives of beta-carbolines from first studies in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

A pretest procedure reliably predicts performance in two animal models of inescapable stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Neural organization of the defensive behavior system responsible for fear

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Dehydroepiandrosterone-sulfate/cortisol ratio in panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Decreased density of benzodiazepine receptors in lymphocytes of anxious patients: reversal after chronic diazepam treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

A biological difference between panic disorder and generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Relationship of generalized anxiety symptoms to urinary 5-hydroxyindoleacetic acid and vanillylmandelic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Anger and anxiety responses to m-chlorophenylpiperazine in generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Effects of the CCK(B) antagonist CI-988 on responses to mCPP in generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Ventilatory physiology of patients with panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Stress and hippocampal neurogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3 alpha, 5 alpha-tetrahydroprogesterone (allopregnanolone) availability?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

5-Hydroxytryptamine pathways in anxiety and its treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Harm avoidance and serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Allelic Variation of Human Serotonin Transporter Gene Expression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Behavioral inhibition and developmental risk: response to commentary.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Somatic manifestations in women with generalized anxiety disorder. Psychophysiological responses to psychological stress

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Fenfluramine, cortisol, and anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Hyperventilation and anxiety in panic disorder, social phobia, GAD and normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Studies of a neurochemical link between depression, anxiety, and stress from [3H]imipramine and [3H]paroxetine binding on human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

The neurobiology of anxiety disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

CSF corticotropin-releasing factor is not affected in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Association between serotonin transporter gene polymorphism and anxiety-related traits.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Generalized anxiety disorder in women. A population-based twin study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Major depression and generalized anxiety disorder. Same genes, (partly) different environments?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Investigation of cholecystokinin system genes in panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Platelet MAO-B activity in anxiety and depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Corticotropin-releasing factor, norepinephrine, and stress

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Fear and the brain: where have we been, and where are we going?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Commentary on the mode of action of benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Biological function of GABAA/benzodiazepine receptor heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Cerebral blood flow changes induced by CO2 in anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Catecholamines and anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Catecholamines and monoamine oxidase activity in anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Pregnenolone and pregnenolone sulfate, alone and with ethanol, in mice on the plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Comorbidity and co-transmission of alcoholism, anxiety and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Generalized anxiety disorder: some biochemical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Molecular diversity of glutamate receptors and implications for brain function

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Prior exposure to chronic stress results in enhanced synthesis and release of hippocampal norepinephrine in response to a novel stressor.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

A family study of generalized anxiety disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

No association between anxiety disorders and catechol-O-methyltransferase polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

A variable-number-tandem-repeat of the serotonin transporter gene and anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Serotonin receptor 1A knockout: an animal model of anxiety-related disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Response to hyperventilation and inhalation of 5.5% carbon dioxide-enriched air across the DSM-III-R anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Peripheral benzodiazepine receptor messenger RNA is decreased in lymphocytes of generalized anxiety disorder patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

A twin study of generalized anxiety disorder and major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Benzodiazepine-induced chemotaxis is impaired in monocytes from patients with generalized anxiety disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Evidence for genetic influences common and specific to symptoms of generalized anxiety and panic.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Noradrenergic function in generalized anxiety disorder, major depressive disorder, and healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

A family study of anxiety disorders: familial transmission and relationship to mood disorder and psychoactive substance use disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

A twin study of DSM-III-R anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Pilot study of a CCKB antagonist in patients with panic disorder: preliminary findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Plasma neuropeptide Y in anxiety disorders: findings in panic disorder and social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Appearance of frontal midline theta activity in patients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Pharmacological and clinical effects of buspirone

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Genetic factors in anxiety disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Anxiolytic properties of 1-aminocyclopropanecarboxylic acid, a ligand at strychnine-insensitive glycine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

1 reference

7 January 2021

Longitudinal course of panic disorder: clinical and biological considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

A 35% carbon dioxide challenge in simple phobias.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

The epidemiology of anxiety disorders: rates, risks and familial patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

DSM-III-R generalized anxiety disorder in the National Comorbidity Survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

A 5-Year Follow-up Study of Generalized Anxiety Disorder and Panic Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Cholecystokinin antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

PET in generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Preferential induction by stress of the N-methyl-D-aspartate recognition domain in discrete structures of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

Phenomenology and course of generalised anxiety disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970207-0

7 January 2021

10.1016/S0193-953X(05)70207-0

Identifiers

DOI

1 reference

6 July 2017

1 reference

PubMed ID

11225510